Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter

被引：0
|
作者：
K. B. Troelsen
E. Ø. Nielsen
N. R. Mirza
机构：
[1] NeuroSearch A/S,
来源：
Psychopharmacology | 2005年 / 181卷
关键词：
Selective serotonin reuptake inhibitor; Serotonin–noradrenaline reuptake inhibitor; Noradrenaline reuptake inhibitor; Tricyclic antidepressant; Serotonin transporter; Noradrenaline tranporter; Anxiety; Mouse; Zero maze;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 750
页数：9
相关论文
共 48 条
  • [31] Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder
    Ramesh, Varsha
    Venkatesan, Vettriselvi
    Ramasamy, Balakrishnan
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [32] Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes
    Rodgers, R. J.
    Augar, R.
    Berryman, N.
    Hansom, C. J.
    O'Mahony, M. L.
    Palmer, R. M.
    Stevens, A.
    Tallett, A. J.
    PSYCHOPHARMACOLOGY, 2006, 187 (03) : 345 - 355
  • [33] Increasing Adiponectin Signaling by Sub-Chronic AdipoRon Treatment Elicits Antidepressant- and Anxiolytic-Like Effects Independent of Changes in Hippocampal Plasticity
    Formolo, Douglas A.
    Lee, Thomas H.
    Yu, Jiasui
    Lin, Kangguang
    Chen, Gang
    Kranz, Georg S.
    Yau, Suk-Yu
    BIOMEDICINES, 2023, 11 (02)
  • [34] Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes
    R. J. Rodgers
    R. Augar
    N. Berryman
    C. J. Hansom
    M. L. O’Mahony
    R. M. Palmer
    A. Stevens
    A. J. Tallett
    Psychopharmacology, 2006, 187 : 345 - 355
  • [35] Serotonin 5-HT1B receptors mediate the antidepressant- and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulation in a mouse model of social defeat
    Esther Silk
    Mustansir Diwan
    Thallita Rabelo
    Hailey Katzman
    Ana Carolina P. Campos
    Flavia Venetucci Gouveia
    Peter Giacobbe
    Nir Lipsman
    Clement Hamani
    Psychopharmacology, 2022, 239 : 3875 - 3892
  • [36] Serotonin 5-HT1B receptors mediate the antidepressant-and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulation in a mouse model of social defeat
    Silk, Esther
    Diwan, Mustansir
    Rabelo, Thallita
    Katzman, Hailey
    Campos, Ana Carolina P.
    Gouveia, Flavia Venetucci
    Giacobbe, Peter
    Lipsman, Nir
    Hamani, Clement
    PSYCHOPHARMACOLOGY, 2022, 239 (12) : 3875 - 3892
  • [37] Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life
    Seripa, Davide
    Pilotto, Andrea
    Paroni, Giulia
    Fontana, Andrea
    D'Onofrio, Grazia
    Gravina, Carolina
    Urbano, Maria
    Cascavilla, Leandro
    Paris, Francesco
    Panza, Francesco
    Padovani, Alessandro
    Pilotto, Alberto
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (05) : 623 - 633
  • [38] Ruscogenin Exerts Anxiolytic-Like Effect via Microglial NF-κB/MAPKs/NLRP3 Signaling Pathways in Mouse Model of Chronic Inflammatory Pain
    Qi, Jing-yu
    Jin, Yu-chen
    Wang, Xin-shang
    Yang, Liu-kun
    Lu, Liang
    Yue, Jiao
    Yang, Fan
    Liu, Yong-sheng
    Jiang, Yong-li
    Song, Da-ke
    Lv, Tao
    Li, Xu-bo
    Zhang, Kun
    Liu, Shui-bing
    PHYTOTHERAPY RESEARCH, 2024, 38 (11) : 5417 - 5440
  • [39] Toll-like receptors 2 and 4 exert opposite effects on the contractile response induced by serotonin in mouse colon: role of serotonin receptors
    Forcen, R.
    Latorre, E.
    Pardo, J.
    Alcalde, A. I.
    Murillo, M. D.
    Grasa, L.
    EXPERIMENTAL PHYSIOLOGY, 2016, 101 (08) : 1064 - 1074
  • [40] A study of chronic vortioxetine in the SERT Met172 mouse suggests antidepressant-like properties that do not require serotonin transporter inhibition
    Nackenoff, A.
    Simmler, L.
    Baganz, N.
    Pehrson, A.
    Sanchez, C.
    Blakely, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S252 - S252
12345